Senti Biosciences (Series B)
Funding Details
Awarder
Inbox
Date Award
January 6, 2021
Vertical
Synthetic Biology
Funding URL
View Funding Page
Funding Amount
$105,000,000
Company Info
Founders
Tim Lu, M.D., Ph.D.
Market
Therapeutics
Location
South San Francisco, California, USA
Coinvestors
Amgen Business Development, Intel Capital, Leaps by Bayer, Lux Capital, Matrix Partners, Mirae Asset Venture Investment, New Enterprise Associates, Ridgeback Capital Management
Company Description

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Synthetic Biology DealsView Funding Announcement